Home » Blog » Cancer Moonshot, Cancer Funding, Genome Mapping

Cancer Moonshot, Cancer Funding, Genome Mapping

IP Blog | Dave Melin | April 16, 2017

BioBlog Weekly oncologyIn this week’s BioBlog, we learn about recent progress in the Cancer Moonshot initiative, potential cuts to cancer research funding, as well as a proposed shift in genome mapping.

A Cancer ‘Moonshot’

In this article we learn how Bloomberg–Kimmel Institute for Cancer Immunotherapy is helping Johns Hopkins further their research in immunotherapy.

Biden Gives Update on Cancer Moonshot at AACR 2017

Biden provided an update on the Cancer Moonshot initiative, including new approaches and collaborations in order to approach cancer research in new ways.

This Start-Up Was Part of Obama’s ‘Cancer Moonshot’ — Now It’s Scrambling After Proposed Trump Cuts

Trump’s proposed budget plans to make cuts to funding of some of the companies that have been participating in Cancer Moonshot research.

Hunt for Cancer ‘Tipping Point’ Heats Up

There is a new call from scientists to shift focus from mapping cancer genomes, to mapping the genomes of tumors before they become cancerous.

5 Highlights from American Association for Cancer Research Conference

In this article, we look at the hot topics recently discussed at the annual American Association for Cancer Research conference, including immunotherapy and funding cuts.

Topics in this Post:

Leave a Comment

Your email address will not be published. Required fields are marked *